Data Privacy and AI in Longevity: Legal Risks Around Predictive Biomarkers and Health Data

Longevity Law Updates, Technology Law Updates

Article by: Lonnie Rosenwald and Carla Pareja Paris Artificial intelligence has become central to the longevity industry. Companies increasingly rely on machine-learning models to analyze biomarkers, genomic data, wearable device outputs, and other health-related inputs to predict disease risk, biological age, or therapeutic response. Many tools, such as the new ChatGPT Health product, invite consumers…